Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Persantine	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Valvuloplasty	O
(___)	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
year	O
old	O
female	O
with	O
3	O
vessel	O
CAD	O
(s/p	O
CABG	O
in	O
___	O
-	O
LIMA	O
to	O
LAD,	O
SVG	O
to	O
LCX,OM	O
and	O
RCA	O
and	O
DES	O
to	O
SVG	O
to	O
RCA	O
and	O
left	O
main	O
___,	O
critical	O
AS	O
(valve	O
area	O
of	O
0.7	O
cm2,	O
mean	O
gradient	O
of	O
39	O
mm	O
Hg	O
and	O
peak	O
gradient	O
of	O
58	O
mm	O
Hg),	O
systolic	O
heart	O
failure	O
with	O
LVEF	O
of	O
___	O
(TTE	O
___,	O
hypertension	O
and	O
dylipidemia.	O
She	O
recently	O
presented	O
to	O
___	O
in	O
___	O
with	O
NSTEMI	O
in	O
setting	O
of	O
acute	O
heart	O
failure	O
and	O
was	O
discharged	O
to	O
rehab	O
on	O
___	O
after	O
DES	O
to	O
left	O
main	O
and	O
SVG	O
to	O
RCA	O
graft.	O
According	O
to	O
her	O
sister,	O
she	O
did	O
well	O
at	O
rehab	O
for	O
few	O
days	O
but	O
had	O
acute	O
episode	O
of	O
shortness	O
of	O
breath	O
and	O
chest	O
pressure	O
leading	O
to	O
admission	O
to	O
___	O
where	O
according	O
to	O
notes	O
was	O
complicated	O
by	O
medically	O
managed	O
NSTEMI,	O
acute	O
on	O
chronic	O
heart	O
failure	O
treated	O
with	O
IV	O
lasix	O
and	O
brief	O
episodes	O
of	O
atrial	O
fibrillation	O
which	O
self	O
terminated.	O
She	O
was	O
subsequently	O
discharged	O
to	O
rehab	O
on	O
___	O
though	O
represented	O
with	O
similar	O
symptoms	O
of	O
shortness	O
of	O
breath	O
and	O
chest	O
pressure	O
on	O
___.	O
She	O
was	O
diuresed	O
with	O
IV	O
lasix	O
and	O
transferred	O
to	O
___	O
for	O
futher	O
evaluation	O
and	O
management.	O
At	O
___,	O
she	O
does	O
not	O
report	O
any	O
other	O
complaints.	O
Past	O
Medical	O
History:	O
.	O
CARDIAC	O
RISK	O
FACTORS:	O
(-)	O
Diabetes,	O
(+)	O
Dyslipidemia,	O
(+)	O
Hypertension	O
2.	O
CARDIAC	O
HISTORY:	O
-CABG:	O
___	O
-	O
3	O
vessel	O
(to	O
LAD,	O
LCX	O
OM	O
and	O
RCA)	O
-PERCUTANEOUS	O
CORONARY	O
INTERVENTIONS:	O
none	O
-PACING/ICD:	O
none	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
s/p	O
left	O
sided	O
CVA	O
in	O
___	O
manifest	O
by	O
lost	B-Visual_impairment
of	O
her	O
peripheral	B-Visual_impairment
vision.	B-Visual_impairment
She	O
is	O
being	O
followed	O
by	O
a	O
neurologist	O
at	O
___,	O
Dr.	O
___.	O
-	O
Glaucoma	B-Visual_impairment
Social	O
History:	O
___	O
Family	O
History:	O
Her	O
mother	O
died	O
of	O
ovarian	O
cancer	O
at	O
age	O
___	O
her	O
father	O
died	O
at	O
___	O
of	O
"old	O
age.	O
There	O
is	O
a	O
family	O
history	O
of	O
coronary	O
artery	O
disease.	O
Physical	O
Exam:	O
Admission	O
Exam	O
98.6	O
83-103/58-68	O
64	O
20	O
100%2___	O
Gen:	O
Elderly	O
female	O
in	O
no	O
acute	O
distress.	O
Alert	O
and	O
oriented	B-Delirium
x	B-Delirium
3.	B-Delirium
Hard	O
of	O
hearing	O
HEENT:	O
JVP	O
~	O
7	O
cm.	O
Anicteric	O
sclera.	O
Moist	O
mucous	O
membranes	O
Chest:	O
CTAB.	O
No	O
crackles	O
or	O
wheezing	O
noted	O
Heart:	O
Late	O
peaking	O
crescendo	O
decrescendo	O
murmur	O
with	O
mild	O
S2	O
radiating	O
to	O
the	O
carotids.	O
No	O
gallop	O
appreciated	O
Abdomen:	O
Soft,	O
NT	O
and	O
ND.	O
NABS	O
External:	O
No	O
edema.	O
No	O
rash	O
Pulse:	O
Faint	O
DP	O
pulses.	O
1+	O
radial	O
pulses	O
Discharge	O
Exam	O
98.0	O
83-107/41-48	O
___	O
93-100%2LNC	O
Wt:	O
63.9	O
kg	O
Gen:	O
Elderly	O
female	O
in	O
no	O
acute	O
distress.	O
Alert	O
and	O
oriented	B-Delirium
x	B-Delirium
3.	B-Delirium
Hard	B-Hearing_impairment
of	B-Hearing_impairment
hearing	B-Hearing_impairment
HEENT:	O
JVP	O
~	O
7	O
cm.	O
Anicteric	O
sclera.	O
Moist	O
mucous	O
membranes	O
Chest:	O
CTAB.	O
No	O
crackles	O
or	O
wheezing	O
noted	O
Heart:	O
Late	O
peaking	O
crescendo	O
decrescendo	O
murmur	O
with	O
mild	O
S2	O
radiating	O
to	O
the	O
carotids.	O
No	O
gallop	O
appreciated	O
Abdomen:	O
Soft,	O
NT	O
and	O
ND.	O
NABS	O
External:	O
No	O
edema.	O
No	O
rash	O
Pulse:	O
Faint	O
DP	O
pulses.	O
1+	O
radial	O
pulses	O
Pertinent	O
Results:	O
___	O
07:30PM	O
BLOOD	O
WBC-12.1*#	O
RBC-3.75*	O
Hgb-11.7*	O
Hct-34.6*	O
MCV-92	O
MCH-31.2	O
MCHC-33.7	O
RDW-14.7	O
Plt	O
___	O
___	O
08:09AM	O
BLOOD	O
WBC-7.9	O
RBC-3.43*	O
Hgb-10.7*	O
Hct-31.5*	O
MCV-92	O
MCH-31.1	O
MCHC-33.8	O
RDW-15.1	O
Plt	O
___	O
___	O
04:44AM	O
BLOOD	O
WBC-7.8	O
RBC-3.25*	O
Hgb-10.2*	O
Hct-29.9*	O
MCV-92	O
MCH-31.5	O
MCHC-34.2	O
RDW-14.9	O
Plt	O
___	O
___	O
08:09AM	O
BLOOD	O
___	O
PTT-29.3	O
___	O
___	O
04:44AM	O
BLOOD	O
___	O
PTT-28.3	O
___	O
___	O
08:09AM	O
BLOOD	O
Glucose-110*	O
UreaN-28*	O
Creat-0.7	O
Na-140	O
K-3.8	O
Cl-103	O
HCO3-28	O
AnGap-13	O
___	O
04:44AM	O
BLOOD	O
Glucose-91	O
UreaN-27*	O
Creat-0.7	O
Na-140	O
K-4.2	O
Cl-104	O
HCO3-23	O
AnGap-17	O
___	O
08:09AM	O
BLOOD	O
ALT-17	O
AST-19	O
LD(LDH)-236	O
AlkPhos-54	O
TotBili-0.3	O
___	O
07:30PM	O
BLOOD	O
Calcium-9.3	O
Phos-4.3	O
Mg-2.0	O
___	O
08:09AM	O
BLOOD	O
Calcium-9.1	O
Phos-3.5	O
Mg-2.0	O
___	O
04:44AM	O
BLOOD	O
Calcium-8.7	O
Phos-3.8	O
Mg-2.0	O
___	O
07:30PM	O
BLOOD	O
CK-MB-4	O
cTropnT-0.17*	O
CXR	O
(___)	O
1.	O
Mild	O
pulmonary	O
edema	O
has	O
completely	O
resolved.	O
2.	O
Stable	O
mild	O
cardiomegaly.	O
TTE	O
(___)	O
The	O
left	O
atrium	O
is	O
normal	O
in	O
size.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy.	O
The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	O
depressed	O
(LVEF	O
=	O
45	O
%)	O
secondary	O
to	O
hypokinesis	O
of	O
the	O
basal	O
inferior	O
and	O
posterior	O
walls	O
as	O
well	O
as	O
of	O
the	O
apex.	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
arch	O
is	O
mildly	O
dilated.	O
There	O
are	O
focal	O
calcifications	O
in	O
the	O
aortic	O
arch.	O
There	O
are	O
three	O
aortic	O
valve	O
leaflets.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened.	O
There	O
is	O
severe	O
aortic	O
valve	O
stenosis	O
(valve	O
area	O
0.8	O
cm2).	O
Trace	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Mild	O
(1+)	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
Compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
the	O
aortic	O
valve	O
orifice	O
area	O
is	O
slightly	O
incerased,	O
and	O
the	O
left	O
ventricular	O
ejection	O
fraction	O
(and	O
stroke	O
volume)	O
are	O
significantly	O
increased.	O
Femoral	O
Groin	O
US	O
(___)	O
No	O
evidence	O
of	O
hematoma	O
or	O
pseudoaneurysm.	O
Valvuloplasty	O
(___)	O
Preliminary	O
Catheterization	O
Report	O
Patient	O
Information	O
Patient	O
Name	O
___,	O
___	O
___	O
Study	O
Date	O
___	O
Number	O
___	O
Date	O
of	O
Birth	O
___	O
___	O
Years	O
GenderFemale	O
Race	O
Height157	O
cm	O
(5'2'')Weight64.90	O
kg	O
(143	O
lbs)	O
BSA1.65	O
M2	O
Procedures:	O
Catheter	O
placement,	O
Coronary	O
Angiography	O
Indications:	O
Aortic	O
stenosis	O
Staff	O
Diagnostic	O
___,	O
MD	O
___,	O
MD	O
___,	O
MD	O
___,	O
RN,	O
MBA	O
___,	O
RN	O
Technologist___,	O
CVT	O
TechnologistMat___,	O
RT(R)	O
Technical	O
Anesthesia:	O
Local	O
Specimens:	O
None	O
Catheter	O
placement	O
via	O
___	O
Fr	O
sheath	O
right	O
femoral	O
artery;	O
___	O
Fr	O
Sheath	O
Right	O
Femoral	O
Vein	O
Balloon	O
aortic	O
valvuloplasty	O
using	O
a	O
22	O
mm	O
x	O
4.___allooon.	O
Blood	O
Oximetry	O
Information	O
Baseline	O
TimeSiteHgb	O
(gm/dL)Sat	O
(%)PO2	O
(mmHg)Content	O
(ml	O
per	O
dl)	O
12:39	O
PMAO	O
___	O
1:02	O
PMPA	O
___	O
Cardiac	O
Output	O
Results	O
PhaseFick	O
C.O.(l/min)Fick	O
C.I.	O
(l/min	O
/m2)TD	O
CO	O
(l/min)TD	O
CI	O
(l/min/m2)	O
Baseline4.192.53	O
Hemodynamic	O
Measurements	O
(mmHg)	O
Baseline	O
SiteSysDiasEndMeanA	O
WaveV	O
WaveHR	O
AO	O
___	O
___	O
___	O
___	O
___	O
___	O
___	O
LV	O
___	O
Contrast	O
Summary	O
ContrastTotal	O
(ml)	O
Omnipaque	O
(300	O
mg/ml)30	O
Radiation	O
Dosage	O
Effective	O
Equivalent	O
Dose	O
Index	O
(mGy)635.23	O
Radiology	O
Summary	O
Total	O
Runs	O
Total	O
Fluoro	O
Time	O
(minutes)20.4	O
Interventional	O
details	O
The	O
distal	O
aortogram	O
demonstrated	O
diffusely	O
diseased	O
iliofemoral	O
vessels	O
with	O
caliber	O
>	O
4.0	O
mm.	O
Balloon	O
aortic	O
valvuloplasty	O
was	O
performed	O
used.	O
The	O
mean	O
aortic	O
valve	O
gradient	O
was	O
57.38	O
mmHg	O
and	O
an	O
aortic	O
valve	O
area	O
0.48	O
cm2.	O
After	O
a	O
single	O
inflation	O
of	O
the	O
aortic	O
valvuloplasty	O
22	O
mm	O
balloon,	O
the	O
residual	O
aortic	O
valve	O
gradient	O
was	O
31.58	O
mmHg	O
and	O
the	O
aortic	O
valve	O
area	O
was	O
0.71	O
cm2.	O
Assessment	O
&	O
Recommendations	O
1.Severe	O
aortic	O
stenosis	O
2.Successful	O
balloon	O
aortic	O
valvuloplasty	O
3.Medical	O
therapy	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
year	O
old	O
female	O
with	O
3	O
vessel	O
CAD	O
(s/p	O
CABG	O
in	O
___	O
-	O
LIMA	O
to	O
LAD,	O
SVG	O
to	O
LCX,OM	O
and	O
RCA	O
and	O
DES	O
to	O
SVG	O
to	O
RCA	O
and	O
left	O
main	O
___,	O
critical	O
AS	O
(valve	O
area	O
of	O
0.7	O
cm2,	O
mean	O
gradient	O
of	O
39	O
mm	O
Hg	O
and	O
peak	O
gradient	O
of	O
58	O
mm	O
Hg),	O
systolic	O
heart	O
failure	O
with	O
LVEF	O
of	O
___	O
(TTE	O
___,	O
hypertension	O
and	O
dylipidemia.	O
She	O
recently	O
presented	O
to	O
___	O
in	O
___	O
with	O
NSTEMI	O
in	O
setting	O
of	O
acute	O
heart	O
failure	O
and	O
was	O
discharged	O
to	O
rehab	O
on	O
___	O
after	O
DES	O
to	O
left	O
main	O
and	O
SVG	O
to	O
RCA	O
graft.	O
She	O
has	O
had	O
two	O
admission	O
for	O
acute	O
on	O
chronic	O
systolic	O
heart	O
failure	O
to	O
___	O
and	O
now	O
transferred	O
to	O
___	O
for	O
further	O
management.	O
She	O
had	O
successful	O
balloon	O
valvuloplasty	O
on	O
___.	O
She	O
was	O
euvolemic	O
on	O
exam	O
upon	O
discharge.	O
1.	O
Acute	O
on	O
chronic	O
systolic	O
heart	O
failure/severe	O
AS/3	O
vessel	O
CAD	O
s/p	O
DES	O
to	O
left	O
main	O
and	O
SVG	O
to	O
RCA	O
graft	O
___.	O
s/p	O
balloon	O
valvuloplasty	O
on	O
___.	O
She	O
was	O
continued	O
on	O
aspirin	O
325	O
daily,	O
plavix	O
75	O
daily,	O
atorvastatin	O
40	O
daily	O
(on	O
amiodarone),	O
metoprolol	O
XL	O
75	O
mg	O
daily	O
and	O
lisinopril	O
2.5	O
mg	O
daily.	O
She	O
should	O
be	O
weighed	O
everyday	O
and	O
if	O
her	O
weight	O
goes	O
up	O
by	O
more	O
than	O
3	O
lbs	O
over	O
one	O
day	O
or	O
5	O
lbs	O
over	O
3	O
days,	O
she	O
should	O
get	O
lasix	O
oral.	O
2.	O
Atrial	O
fibrillation:	O
Continued	O
amiodarone	O
200	O
mg	O
BID	O
for	O
rhythm	O
control	O
which	O
will	O
need	O
to	O
be	O
decreased	O
200	O
mg	O
daily	O
on	O
___	O
.	O
Continued	O
metoprolol	O
for	O
rate	O
control.	O
On	O
asa/plavix	O
for	O
anticoagulation	O
with	O
CHADS2	O
of	O
5.	O
3.	O
Glaucoma:	B-Visual_impairment
Continue	O
home	O
eye	O
drops	O
4.	O
Depression/Anxiety:	O
Continue	O
quetiapine	O
and	O
venlafaxine.	O
Transitional	O
issues:	O
1.	O
She	O
should	O
be	O
weighed	O
everyday	O
and	O
if	O
her	O
weight	O
goes	O
up	O
by	O
more	O
than	O
3	O
lbs	O
over	O
one	O
day	O
or	O
5	O
lbs	O
over	O
3	O
days,	O
she	O
should	O
get	O
lasix	O
oral.	O
2.	O
Amiodarone	O
will	O
need	O
to	O
be	O
decreased	O
200	O
mg	O
daily	O
on	O
___	O
Medications	O
on	O
Admission:	O
Aspirin	O
325	O
mg	O
PO/NG	O
DAILY	O
Clopidogrel	O
75	O
mg	O
PO/NG	O
DAILY	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
Lisinopril	O
2.5	O
mg	O
PO/NG	O
DAILY	O
Amiodarone	O
200	O
mg	O
PO/NG	O
BID	O
Atorvastatin	O
40	O
mg	O
PO/NG	O
HS	O
Quetiapine	O
Fumarate	O
25	O
mg	O
PO/NG	O
QHS	O
Venlafaxine	O
XR	O
75	O
mg	O
PO	O
DAILY	O
Lumigan	O
*NF*	O
(bimatoprost)	O
0.01	O
%	O
___	O
HS	O
Brimonidine	O
Tartrate	O
0.15%	O
Ophth.	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
Dorzolamide	O
2%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
Senna	O
2	O
TAB	O
PO/NG	O
HS	O
Polyethylene	O
Glycol	O
17	O
g	O
PO/NG	O
DAILY	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Amiodarone	O
200	O
mg	O
PO	O
BID	O
2.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
40	O
mg	O
PO	O
HS	O
4.	O
Brimonidine	O
Tartrate	O
0.15%	O
Ophth.	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
5.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
6.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
7.	O
Dorzolamide	O
2%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
8.	O
Lisinopril	O
2.5	O
mg	O
PO	O
DAILY	O
9.	O
Lorazepam	O
0.5	O
mg	O
PO	O
Q4H:PRN	O
anxiety	O
10.	O
Lumigan	O
*NF*	O
(bimatoprost)	O
0.01	O
%	O
___	O
HS	O
11.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
12.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
13.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
14.	O
Quetiapine	O
Fumarate	O
25	O
mg	O
PO	O
QHS	O
15.	O
Senna	O
2	O
TAB	O
PO	O
HS	O
16.	O
Venlafaxine	O
XR	O
75	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
1.	O
Severe	O
aortic	O
stenosis	O
s/p	O
valvuloplasty	O
2.	O
Acute	O
on	O
chronic	O
systolic	O
left	O
sided	O
heart	O
failure	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
You	O
were	O
transferred	O
to	O
the	O
hospital	O
with	O
heart	O
failure	O
in	O
setting	O
of	O
your	O
severe	O
aortic	O
valve	O
stenosis.	O
You	O
received	O
valvuloplasty	O
and	O
are	O
being	O
discharged	O
to	O
rehab.	O
Followup	O
Instructions:	O
___	O

